Kontafarma China Holdings Ltd (1312) Income Statement

0 Followers

Kontafarma China Holdings Ltd Income Statement

Last quarter (Q4 2025), Kontafarma China Holdings Ltd's total revenue was HK$461.99M, an increase of 22.09% from the same quarter last year. In Q4, Kontafarma China Holdings Ltd's net income was HK$-145.36M. See Kontafarma China Holdings Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 914.71M	HK$ 897.52M	HK$ 809.11M	HK$ 894.06M	HK$ 803.27M
Gross Profit	HK$ 513.64M	HK$ 516.16M	HK$ 471.29M	HK$ 506.22M	HK$ 396.18M
Operating Expenses	HK$ 558.53M	HK$ 558.67M	HK$ 563.62M	HK$ 590.63M	HK$ 502.98M
Depreciation and Amortization	HK$ 30.57M	HK$ 42.49M	HK$ 107.16M	HK$ 121.39M	HK$ 133.03M
EBITDA	HK$ -14.32M	HK$ -49.93M	HK$ 78.50M	HK$ 26.93M	HK$ 112.18M
Operating Income	HK$ -44.90M	HK$ -42.51M	HK$ -164.30M	HK$ -137.29M	HK$ -97.71M
Other Income/Expenses	HK$ -409.83M	HK$ -55.47M	HK$ 120.38M	HK$ 19.56M	HK$ 0.00
Pretax Income	HK$ -454.73M	HK$ -97.98M	HK$ -43.92M	HK$ -117.74M	HK$ -54.47M
Net Income	HK$ -427.85M	HK$ -75.54M	HK$ -28.84M	HK$ -41.55M	HK$ -15.05M
Per Share Metrics
Basic EPS	HK$ -0.08	HK$ -0.01	HK$ -0.01	HK$ -0.01	HK$ 0.00
Diluted EPS	HK$ -0.08	HK$ -0.01	HK$ -0.01	HK$ -0.01	HK$ 0.00
Weighted Average Shares Outstanding	5.58B	5.58B	5.58B	5.58B	5.58B
Weighted Average Shares Outstanding (Diluted)	5.58B	5.58B	5.58B	5.58B	5.58B

Currency in HKD

Kontafarma China Holdings Ltd (1312) Income Statement

Kontafarma China Holdings Ltd Income Statement

Kontafarma China Holdings Ltd Earnings and Revenue History